Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Working Capital/Sales

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.882.391.742.292.64

What is the latest Working Capital/Sales ratio of MEDICAMEN BIOTECH ?

The latest Working Capital/Sales ratio of MEDICAMEN BIOTECH is 1.88 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.88
Mar20242.39
Mar20231.74
Mar20222.29
Mar20212.64

How is Working Capital/Sales of MEDICAMEN BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2025 1.88
-21.34
Mar2024 2.39
37.36
Mar2023 1.74
-24.02
Mar2022 2.29
-13.26
Mar2021 2.64 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Working Capital/Sales ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹479.2 Cr -1.7% -10.9% -23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-1.7%

-10.9%

-23.1%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses